Need help? Talk to one of our pharmacists: 0330 123 3001
The MHRA have granted Thistle Pharma an MS (Import) license to permit the importation of pharmaceuticals not licensed in the UK, but licensed anyhere in the world. Our extensive network of approved international suppliers means that we can access portfolios in most territories. If you manage patients with a requirement for such rare or unusual therapy, then let us manage your procurement needs and deliver product to support their unmet needs.
From time to time, there can be shortages or out of stock circumstances with UK licensed products. This can create a circumstance of unmet need for some patients, particularly where there are no licensed alternatives. Our specialist MS(Import) licensure enables us to seek MHRA consent to import international equivalents of these medicines to support UK patients during such shortages. For more information about this service, Healthcare Professionals should reach out to us at contactus@thistlepharma.com.
Patients or members of the UK general public should discuss any unmet need or requirement for the use of unlicensed medicines with a Healthcare professional prior to reaching out to us for signposting.
At Thistle, we’ve been successfully supporting our Pharma clients around market access for some years. We use a blend of data-derived insights and our broad experience to propose strategy and direct implementation. With a speciality in digital listing interfaces associated with the varied clinical and supply chain cascades, we ensure our clients products are discoverable where and when they’re needed.
From amongst our broad network of partners, Thistle Pharma can offer outsource bespoke and batch manufacture across a broad portfolio of products and presentations from GSL and Food Supplements to aseptic and controlled substances. Whether you’re looking for a partner to manage your production needs from end to end or simply need signposting, give us a call to see if we can help.
Managed Access Programs (MAPs) comprise a variety of regulatory approaches to providing access to unapproved essential medicines outside a clinical trial or commercial setting for example when a product is in the pre-approved phase of development in one or more territories. At Thistle Pharma our regulatory architecture and multidisciplinary network means we can leverage end to end key capabilities to support Pharma in such early access ventures.
If you’re looking for a solution-led partner that understands compliance and GDP fulfilment, then let us support you via our network of subcontractors and specialist service providers. With successful healthcare operations in most regulatory segments, if we don’t already have it, we’ll build a model which will work for you.
At Thistle Pharma, our specialist pharmacists and technicians are here to give you the answers you need at the point of order. With a wealth of experience and access to a plethora of varied databases, we see ourselves as an extension to your pharmacy team, resourcing peer to peer support for you to deliver as a healthcare professional within your practice. Whatever the question, be it about formulation, availability, lead-times, shelf-life or just regulatory support, we’re here to give you the answers when you need them.